SCHEDULE 14A
(RULE 14A-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
SUPPLEMENT TO PROXY STATEMENT PURSUANT TO SECTION 14(A)
OF THE SECURITIES EXCHANGE ACT OF 1934
Filed by the Registrant {X}
Filed by a Party Other than the Registrant { }
Check the appropriate box:
{ } Preliminary Proxy Statement
{ } Confidential, for Use of the Commission only (as permitted by Rule
14a-6(e)(2))
{ } Definitive Proxy Statement
{X } Definitive Additional Materials
{ } Soliciting Material Pursuant to ss. 240.14a-11(c) or ss. 240.14a-12
SCHEIN PHARMACEUTICAL, INC.
(Name of Registrant as Specified in its Charter)
- --------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
{X} No fee required.
{ } Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
1. Title of each class of securities to which transaction applies:
2. Aggregate number of securities to which transaction applies:
3. Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11:
4. Proposed maximum aggregate value of transaction:
5. Total fee paid:
{ } Fee paid previously with preliminary materials.
{ } Check box if any part of the fee is offset as provided by
Exchange Act Rule 0-11(a)(2) and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing by
registration statement number, or the Form or Schedule and the date of
its filing.
1. Amount Previously Paid:
2. Form, Schedule or Registration Statement No.:
3. Filing Party:
4. Date Filed:
<PAGE>
SCHEIN PHARMACEUTICAL, INC.
100 CAMPUS DRIVE
FLORHAM PARK, NEW JERSEY 07932
May 10, 2000
Dear Stockholder:
We recently reported, among other things, that we have added Messrs.
Marvin Schein and Irving Shafran to our board of directors, bringing the total
number of directors on the board to nine and that our Annual Meeting of
Stockholders currently scheduled for May 16, 2000 will be adjourned to a later
date.
It is not necessary for you to attend the May 16, 2000 meeting or to
return the white proxy card distributed with the Company's April 14, 2000 proxy
statement. Supplemental proxy material will be sent to you in advance of the
adjourned meeting with respect to new proxies that will be requested.
Sincerely,
/s/ Paul Feuerman
Paul Feuerman
Secretary
